Assessment of BHB Concentration Agreement Among Sampling Locations and the Impact of Ketosis on EPO, and More
Ketosis
About this trial
This is an interventional basic science trial for Ketosis focused on measuring ketosis, ketone monoester, erythropoitin, sex hormones
Eligibility Criteria
Inclusion Criteria: Age 18-60 years BMI 19-30 kg/m2 Expected ease of catheter insertion Considered of sound health Oral and written informed consent Exclusion Criteria: Inability to fully understand the consent including consent forms Inability to cooperate to the study electrolyte disorders acute or chronic kidney disease or ompromised renal function including excess risk servere hypertension autoimmune disease liver or bile disease diabetes mellitus reactive hypoglycemia or similar disorders treatment with drugs, and dietary supplements with inference on key metabolic or hormonal markers, e.g. insulin, glucagon, DDP-IV inhibitors, GLP-1 RA, sulfunylurea use of illegal or otherwise use of medicinal products without prescription anemia or other know disease of the hematopoietic system previous bariatric surgery previous myocardial infarction or uncontrolled myocardial ischemia recent intended/unintended weight loss allergies to catheters or adhesives
Sites / Locations
- Department of Internal Medicine, Viborg Regional HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Ketosis
Control
Ketosis (the condition being investigated) is obtained by ingestion of a ketone monoester
The control arm is a drink matched in taste, volume, appearence, and viscosity to that of the active/experimental arm